Le malattie infiammatorie intestinali (IBD) sono un gruppo di condizioni complesse e croniche, caratterizzate dall’infiammazione prolungata del tratto gastrointestinale, che può avere un impatto a lungo termine sulla qualità di vita dei pazienti.

Referenze

Ungaro R, et al. Ulcerative colitis. Lancet. 2017;389:1756-70.

Torres J, et al. Crohn's disease. Lancet. 2017;389:1741-55.

Crohn’s and Colitis UK. Tests and Investigations for IBD. [Internet; cited 2019 April 25]. Available at: https://www.crohnsandcolitis.org.uk/about-inflammatory-bowel-disease/publications/tests-and-investigations-for-ibd.

Jung SA. Differential diagnosis of inflammatory bowel disease: what is the role of colonoscopy? Clinical Endoscopy. 2012;45:254-62.

Medscape. Inflammatory Bowel Disease. [Internet; cited 2019 April 25]. Available at: https://emedicine.medscape.com/article/179037-overview.

Nasiri S, et al. Long-term outcomes of pediatric inflammatory bowel disease. Semin Pediatr Surg. 2017;26:398-404.

Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.

M'Koma EA. Inflammatory bowel disease: An expanding global health problem. Clinical Medical Insights Gastroenterology. 2013;3:33-47.

Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.

10 Dave M, et al. Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics. Gastroenterol Clin North Am. 2014; 43: 405–24.

11 Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. The American Journal of Gastroenterology 2006;101:110-8.

12 Sandborn WJ. The Present and Future of Inflammatory Bowel Disease Treatment. Gastroenterol Hepatol.. 2016; 12: 438–41.

13 Stein RB, Hanauer SB. Comparative tolerability of treatments for inflammatory bowel disease. Drug Safety 2000;23:429-48.